-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Protalix BioTherapeutics, Inc. quarterly/annual Current Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
- Protalix BioTherapeutics, Inc. Current Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was -$382K.
- Protalix BioTherapeutics, Inc. Current Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was $3.35M.
- Protalix BioTherapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $3.35M, a 531% increase from 2022.
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)